nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—NOS3—type 2 diabetes mellitus	0.434	0.783	CbGaD
Tetrahydrobiopterin—PTGS2—type 2 diabetes mellitus	0.12	0.217	CbGaD
Tetrahydrobiopterin—NOS3—femoral artery—type 2 diabetes mellitus	0.0201	0.168	CbGeAlD
Tetrahydrobiopterin—NOS3—middle cerebral artery—type 2 diabetes mellitus	0.0138	0.116	CbGeAlD
Tetrahydrobiopterin—NOS3—arteriole—type 2 diabetes mellitus	0.0122	0.102	CbGeAlD
Tetrahydrobiopterin—NOS3—tunica intima—type 2 diabetes mellitus	0.00865	0.0723	CbGeAlD
Tetrahydrobiopterin—TH—sympathetic nervous system—type 2 diabetes mellitus	0.00864	0.0721	CbGeAlD
Tetrahydrobiopterin—TPH1—nerve—type 2 diabetes mellitus	0.00686	0.0573	CbGeAlD
Tetrahydrobiopterin—NOS3—penis—type 2 diabetes mellitus	0.0064	0.0534	CbGeAlD
Tetrahydrobiopterin—TH—autonomic nervous system—type 2 diabetes mellitus	0.00581	0.0485	CbGeAlD
Tetrahydrobiopterin—NOS3—hindlimb—type 2 diabetes mellitus	0.00483	0.0404	CbGeAlD
Tetrahydrobiopterin—TH—peripheral nervous system—type 2 diabetes mellitus	0.00419	0.035	CbGeAlD
Tetrahydrobiopterin—TH—artery—type 2 diabetes mellitus	0.00329	0.0275	CbGeAlD
Tetrahydrobiopterin—TH—nerve—type 2 diabetes mellitus	0.00327	0.0273	CbGeAlD
Tetrahydrobiopterin—NOS3—artery—type 2 diabetes mellitus	0.00296	0.0247	CbGeAlD
Tetrahydrobiopterin—NOS3—endothelium—type 2 diabetes mellitus	0.0025	0.0209	CbGeAlD
Tetrahydrobiopterin—PAH—kidney—type 2 diabetes mellitus	0.00185	0.0154	CbGeAlD
Tetrahydrobiopterin—PTGS2—leg—type 2 diabetes mellitus	0.00171	0.0143	CbGeAlD
Tetrahydrobiopterin—PTGS2—hindlimb—type 2 diabetes mellitus	0.00153	0.0128	CbGeAlD
Tetrahydrobiopterin—TH—retina—type 2 diabetes mellitus	0.00135	0.0113	CbGeAlD
Tetrahydrobiopterin—PAH—liver—type 2 diabetes mellitus	0.00117	0.00974	CbGeAlD
Tetrahydrobiopterin—TH—cardiovascular system—type 2 diabetes mellitus	0.00114	0.00955	CbGeAlD
Tetrahydrobiopterin—TH—kidney—type 2 diabetes mellitus	0.00112	0.00935	CbGeAlD
Tetrahydrobiopterin—NOS3—cardiovascular system—type 2 diabetes mellitus	0.00103	0.0086	CbGeAlD
Tetrahydrobiopterin—NOS3—kidney—type 2 diabetes mellitus	0.00101	0.00841	CbGeAlD
Tetrahydrobiopterin—PTGS2—artery—type 2 diabetes mellitus	0.000939	0.00784	CbGeAlD
Tetrahydrobiopterin—PTGS2—endothelium—type 2 diabetes mellitus	0.000793	0.00662	CbGeAlD
Tetrahydrobiopterin—NOS3—liver—type 2 diabetes mellitus	0.000637	0.00532	CbGeAlD
Tetrahydrobiopterin—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000451	0.00377	CbGeAlD
Tetrahydrobiopterin—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000326	0.00272	CbGeAlD
Tetrahydrobiopterin—PTGS2—kidney—type 2 diabetes mellitus	0.000319	0.00267	CbGeAlD
Tetrahydrobiopterin—PTGS2—pancreas—type 2 diabetes mellitus	0.000317	0.00265	CbGeAlD
Tetrahydrobiopterin—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000316	0.00198	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000315	0.00198	CcSEcCtD
Tetrahydrobiopterin—Infection—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00197	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000313	0.00196	CcSEcCtD
Tetrahydrobiopterin—Nausea—Nateglinide—type 2 diabetes mellitus	0.000312	0.00196	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000311	0.00195	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000311	0.00195	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00031	0.00195	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000309	0.00194	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000308	0.00193	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.000308	0.00193	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000307	0.00193	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000307	0.00193	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Glyburide—type 2 diabetes mellitus	0.000307	0.00193	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000303	0.0019	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000303	0.0019	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000302	0.0019	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000302	0.00189	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000301	0.00189	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000299	0.00188	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Ramipril—type 2 diabetes mellitus	0.000298	0.00187	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000297	0.00187	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000294	0.00185	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000294	0.00184	CcSEcCtD
Tetrahydrobiopterin—Agitation—Gliclazide—type 2 diabetes mellitus	0.000293	0.00184	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000292	0.00184	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000289	0.00181	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000289	0.00181	CcSEcCtD
Tetrahydrobiopterin—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000288	0.0024	CbGeAlD
Tetrahydrobiopterin—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000287	0.0018	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000287	0.0018	CcSEcCtD
Tetrahydrobiopterin—Rash—Repaglinide—type 2 diabetes mellitus	0.000287	0.0018	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000286	0.0018	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000286	0.0018	CcSEcCtD
Tetrahydrobiopterin—Headache—Repaglinide—type 2 diabetes mellitus	0.000285	0.00179	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000284	0.00179	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000284	0.00178	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000284	0.00178	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000279	0.00175	CcSEcCtD
Tetrahydrobiopterin—Cough—Gliclazide—type 2 diabetes mellitus	0.000278	0.00174	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000277	0.00174	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000277	0.00174	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000276	0.00174	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000276	0.00173	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000276	0.00173	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000273	0.00172	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000272	0.00171	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000271	0.0017	CcSEcCtD
Tetrahydrobiopterin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000271	0.0017	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000271	0.0017	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000271	0.0017	CcSEcCtD
Tetrahydrobiopterin—Nausea—Repaglinide—type 2 diabetes mellitus	0.00027	0.00169	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Losartan—type 2 diabetes mellitus	0.00027	0.00169	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000269	0.00169	CcSEcCtD
Tetrahydrobiopterin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000269	0.00169	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Metformin—type 2 diabetes mellitus	0.000266	0.00167	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000265	0.00167	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000264	0.00165	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.00026	0.00163	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00162	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000259	0.00162	CcSEcCtD
Tetrahydrobiopterin—Infection—Gliclazide—type 2 diabetes mellitus	0.000258	0.00162	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000258	0.00162	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000257	0.00161	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000256	0.00161	CcSEcCtD
Tetrahydrobiopterin—Cough—Valsartan—type 2 diabetes mellitus	0.000255	0.0016	CcSEcCtD
Tetrahydrobiopterin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000255	0.0016	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000255	0.0016	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000255	0.0016	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000254	0.0016	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000252	0.00158	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000252	0.00158	CcSEcCtD
Tetrahydrobiopterin—Cough—Orlistat—type 2 diabetes mellitus	0.000252	0.00158	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000251	0.00158	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Orlistat—type 2 diabetes mellitus	0.00025	0.00157	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00025	0.00157	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00025	0.00157	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00025	0.00157	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000249	0.00156	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000249	0.00156	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000247	0.00155	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000246	0.00155	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000244	0.00153	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00024	0.00151	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000239	0.0015	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000239	0.0015	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000239	0.0015	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000238	0.0015	CcSEcCtD
Tetrahydrobiopterin—Infection—Valsartan—type 2 diabetes mellitus	0.000237	0.00149	CcSEcCtD
Tetrahydrobiopterin—Rash—Glipizide—type 2 diabetes mellitus	0.000237	0.00149	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000237	0.00149	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000237	0.00149	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000237	0.00149	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000236	0.00148	CcSEcCtD
Tetrahydrobiopterin—Headache—Glipizide—type 2 diabetes mellitus	0.000236	0.00148	CcSEcCtD
Tetrahydrobiopterin—Infection—Orlistat—type 2 diabetes mellitus	0.000234	0.00147	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000234	0.00147	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000232	0.00146	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000232	0.00146	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000231	0.00145	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000231	0.00145	CcSEcCtD
Tetrahydrobiopterin—Agitation—Irbesartan—type 2 diabetes mellitus	0.000231	0.00145	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.00023	0.00144	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000229	0.00144	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000229	0.00144	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000229	0.00144	CcSEcCtD
Tetrahydrobiopterin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000226	0.00142	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000225	0.00141	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000224	0.00141	CcSEcCtD
Tetrahydrobiopterin—Nausea—Glipizide—type 2 diabetes mellitus	0.000223	0.0014	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000223	0.0014	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000222	0.0014	CcSEcCtD
Tetrahydrobiopterin—Rash—Glimepiride—type 2 diabetes mellitus	0.000221	0.00139	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000221	0.00139	CcSEcCtD
Tetrahydrobiopterin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00138	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00138	CcSEcCtD
Tetrahydrobiopterin—Headache—Glimepiride—type 2 diabetes mellitus	0.00022	0.00138	CcSEcCtD
Tetrahydrobiopterin—Cough—Irbesartan—type 2 diabetes mellitus	0.000219	0.00138	CcSEcCtD
Tetrahydrobiopterin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00138	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000217	0.00137	CcSEcCtD
Tetrahydrobiopterin—Agitation—Losartan—type 2 diabetes mellitus	0.000217	0.00136	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000217	0.00136	CcSEcCtD
Tetrahydrobiopterin—Infection—Metformin—type 2 diabetes mellitus	0.000216	0.00136	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000215	0.00135	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000214	0.00134	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000213	0.00134	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000213	0.00134	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000213	0.00133	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000212	0.00133	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000211	0.00133	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00021	0.00132	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.00021	0.00132	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000209	0.00131	CcSEcCtD
Tetrahydrobiopterin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000208	0.00131	CcSEcCtD
Tetrahydrobiopterin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000208	0.0013	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000208	0.0013	CcSEcCtD
Tetrahydrobiopterin—Cough—Losartan—type 2 diabetes mellitus	0.000206	0.0013	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000206	0.00129	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000205	0.00129	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000205	0.00129	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000205	0.00129	CcSEcCtD
Tetrahydrobiopterin—Infection—Irbesartan—type 2 diabetes mellitus	0.000204	0.00128	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000204	0.00128	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000203	0.00127	CcSEcCtD
Tetrahydrobiopterin—PTGS2—liver—type 2 diabetes mellitus	0.000202	0.00168	CbGeAlD
Tetrahydrobiopterin—Arthralgia—Losartan—type 2 diabetes mellitus	0.000201	0.00126	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00126	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000201	0.00126	CcSEcCtD
Tetrahydrobiopterin—Rash—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00125	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00125	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000199	0.00125	CcSEcCtD
Tetrahydrobiopterin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00124	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000198	0.00124	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000198	0.00124	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000195	0.00123	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000193	0.00121	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000193	0.00121	CcSEcCtD
Tetrahydrobiopterin—Infection—Losartan—type 2 diabetes mellitus	0.000192	0.0012	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000191	0.0012	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000191	0.0012	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000189	0.00119	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000189	0.00118	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00118	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000188	0.00118	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000187	0.00117	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000186	0.00117	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000186	0.00117	CcSEcCtD
Tetrahydrobiopterin—Agitation—Ramipril—type 2 diabetes mellitus	0.000186	0.00117	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000184	0.00115	CcSEcCtD
Tetrahydrobiopterin—Rash—Glyburide—type 2 diabetes mellitus	0.000182	0.00115	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000182	0.00114	CcSEcCtD
Tetrahydrobiopterin—Headache—Glyburide—type 2 diabetes mellitus	0.000181	0.00114	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000181	0.00113	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000178	0.00112	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000178	0.00112	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000177	0.00111	CcSEcCtD
Tetrahydrobiopterin—Cough—Ramipril—type 2 diabetes mellitus	0.000177	0.00111	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000176	0.0011	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000176	0.0011	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000176	0.0011	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000174	0.00109	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000173	0.00108	CcSEcCtD
Tetrahydrobiopterin—Nausea—Glyburide—type 2 diabetes mellitus	0.000172	0.00108	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000172	0.00108	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000172	0.00108	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000171	0.00108	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00017	0.00107	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000168	0.00105	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000166	0.00104	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000165	0.00104	CcSEcCtD
Tetrahydrobiopterin—Rash—Gliclazide—type 2 diabetes mellitus	0.000164	0.00103	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000164	0.00103	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000163	0.00103	CcSEcCtD
Tetrahydrobiopterin—Headache—Gliclazide—type 2 diabetes mellitus	0.000163	0.00102	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000162	0.00102	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000162	0.00102	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000162	0.00102	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000161	0.00101	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000161	0.00101	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000158	0.000991	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000158	0.000991	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000156	0.000979	CcSEcCtD
Tetrahydrobiopterin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000154	0.000969	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000153	0.000958	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000153	0.000958	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000152	0.000953	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000151	0.000949	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000151	0.000947	CcSEcCtD
Tetrahydrobiopterin—Rash—Valsartan—type 2 diabetes mellitus	0.000151	0.000945	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00015	0.000944	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Orlistat—type 2 diabetes mellitus	0.00015	0.000941	CcSEcCtD
Tetrahydrobiopterin—Headache—Valsartan—type 2 diabetes mellitus	0.00015	0.000939	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000149	0.000934	CcSEcCtD
Tetrahydrobiopterin—Rash—Orlistat—type 2 diabetes mellitus	0.000149	0.000934	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000149	0.000933	CcSEcCtD
Tetrahydrobiopterin—Headache—Orlistat—type 2 diabetes mellitus	0.000148	0.000928	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000146	0.000915	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Metformin—type 2 diabetes mellitus	0.000144	0.000902	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000143	0.000897	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000142	0.000893	CcSEcCtD
Tetrahydrobiopterin—Nausea—Valsartan—type 2 diabetes mellitus	0.000142	0.00089	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00014	0.000881	CcSEcCtD
Tetrahydrobiopterin—Nausea—Orlistat—type 2 diabetes mellitus	0.00014	0.00088	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Metformin—type 2 diabetes mellitus	0.000138	0.000868	CcSEcCtD
Tetrahydrobiopterin—Rash—Metformin—type 2 diabetes mellitus	0.000137	0.00086	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000137	0.00086	CcSEcCtD
Tetrahydrobiopterin—Headache—Metformin—type 2 diabetes mellitus	0.000136	0.000855	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000136	0.000852	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000135	0.00085	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000132	0.000829	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000131	0.000822	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000131	0.000822	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00013	0.000819	CcSEcCtD
Tetrahydrobiopterin—Rash—Irbesartan—type 2 diabetes mellitus	0.000129	0.000812	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000129	0.000811	CcSEcCtD
Tetrahydrobiopterin—Nausea—Metformin—type 2 diabetes mellitus	0.000129	0.000811	CcSEcCtD
Tetrahydrobiopterin—Headache—Irbesartan—type 2 diabetes mellitus	0.000129	0.000807	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Losartan—type 2 diabetes mellitus	0.000128	0.000801	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Losartan—type 2 diabetes mellitus	0.000123	0.000771	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000122	0.000766	CcSEcCtD
Tetrahydrobiopterin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000122	0.000765	CcSEcCtD
Tetrahydrobiopterin—Rash—Losartan—type 2 diabetes mellitus	0.000122	0.000764	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000122	0.000763	CcSEcCtD
Tetrahydrobiopterin—Headache—Losartan—type 2 diabetes mellitus	0.000121	0.000759	CcSEcCtD
Tetrahydrobiopterin—Nausea—Losartan—type 2 diabetes mellitus	0.000115	0.00072	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000113	0.000711	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000109	0.000687	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000105	0.000661	CcSEcCtD
Tetrahydrobiopterin—Rash—Ramipril—type 2 diabetes mellitus	0.000104	0.000655	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000104	0.000655	CcSEcCtD
Tetrahydrobiopterin—Headache—Ramipril—type 2 diabetes mellitus	0.000104	0.000651	CcSEcCtD
Tetrahydrobiopterin—Nausea—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000617	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.57e-05	9.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—APOA1—type 2 diabetes mellitus	1.57e-05	9.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—LPL—type 2 diabetes mellitus	1.56e-05	9.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.56e-05	9.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.54e-05	9.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.53e-05	9.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ADCY5—type 2 diabetes mellitus	1.53e-05	9.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.53e-05	9.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.53e-05	9.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.53e-05	9.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3R1—type 2 diabetes mellitus	1.51e-05	9.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—NOS3—type 2 diabetes mellitus	1.51e-05	9.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.51e-05	9.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—SRC—type 2 diabetes mellitus	1.5e-05	8.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PPP2CA—type 2 diabetes mellitus	1.47e-05	8.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VEGFA—type 2 diabetes mellitus	1.46e-05	8.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PCK1—type 2 diabetes mellitus	1.46e-05	8.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—STAR—type 2 diabetes mellitus	1.46e-05	8.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.46e-05	8.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ACACA—type 2 diabetes mellitus	1.46e-05	8.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CCR5—type 2 diabetes mellitus	1.44e-05	8.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.44e-05	8.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GNB3—type 2 diabetes mellitus	1.44e-05	8.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.44e-05	8.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—HMOX1—type 2 diabetes mellitus	1.43e-05	8.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.42e-05	8.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TLE4—type 2 diabetes mellitus	1.42e-05	8.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CAT—type 2 diabetes mellitus	1.41e-05	8.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTHFR—type 2 diabetes mellitus	1.41e-05	8.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	1.4e-05	8.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	1.4e-05	8.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.4e-05	8.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GCG—type 2 diabetes mellitus	1.4e-05	8.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—type 2 diabetes mellitus	1.38e-05	8.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PPARG—type 2 diabetes mellitus	1.38e-05	8.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.37e-05	8.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOB—type 2 diabetes mellitus	1.37e-05	8.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.37e-05	8.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HK1—type 2 diabetes mellitus	1.37e-05	8.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—INS—type 2 diabetes mellitus	1.35e-05	8.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.35e-05	8.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	1.35e-05	8.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HIF1A—type 2 diabetes mellitus	1.34e-05	8.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TGFB1—type 2 diabetes mellitus	1.34e-05	8.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IRS2—type 2 diabetes mellitus	1.34e-05	8.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.34e-05	8.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTM1—type 2 diabetes mellitus	1.33e-05	7.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—SRC—type 2 diabetes mellitus	1.33e-05	7.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	1.33e-05	7.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	1.32e-05	7.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.32e-05	7.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GCKR—type 2 diabetes mellitus	1.32e-05	7.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CALM1—type 2 diabetes mellitus	1.32e-05	7.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APOE—type 2 diabetes mellitus	1.31e-05	7.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—LPL—type 2 diabetes mellitus	1.31e-05	7.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.3e-05	7.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	1.3e-05	7.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	1.3e-05	7.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.3e-05	7.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APOA1—type 2 diabetes mellitus	1.3e-05	7.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ADCY5—type 2 diabetes mellitus	1.28e-05	7.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GPX1—type 2 diabetes mellitus	1.28e-05	7.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	1.27e-05	7.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.26e-05	7.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CD36—type 2 diabetes mellitus	1.24e-05	7.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ALB—type 2 diabetes mellitus	1.24e-05	7.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.23e-05	7.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	1.22e-05	7.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NOS2—type 2 diabetes mellitus	1.22e-05	7.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.21e-05	7.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	1.21e-05	7.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.2e-05	7.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.2e-05	7.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.2e-05	7.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TGFB1—type 2 diabetes mellitus	1.19e-05	7.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AVP—type 2 diabetes mellitus	1.19e-05	7.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.19e-05	7.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3R1—type 2 diabetes mellitus	1.19e-05	7.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NOS3—type 2 diabetes mellitus	1.19e-05	7.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.18e-05	7.08e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—MTHFR—type 2 diabetes mellitus	1.18e-05	7.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.18e-05	7.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RBP4—type 2 diabetes mellitus	1.18e-05	7.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.17e-05	7.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.17e-05	7.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—type 2 diabetes mellitus	1.17e-05	7e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IRS1—type 2 diabetes mellitus	1.17e-05	7e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARA—type 2 diabetes mellitus	1.16e-05	6.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOB—type 2 diabetes mellitus	1.15e-05	6.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	1.14e-05	6.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.14e-05	6.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.14e-05	6.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.13e-05	6.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AGT—type 2 diabetes mellitus	1.12e-05	6.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—INS—type 2 diabetes mellitus	1.12e-05	6.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.12e-05	6.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	1.11e-05	6.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.11e-05	6.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	1.11e-05	6.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.11e-05	6.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CALM1—type 2 diabetes mellitus	1.1e-05	6.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOE—type 2 diabetes mellitus	1.1e-05	6.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	1.1e-05	6.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LPL—type 2 diabetes mellitus	1.1e-05	6.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—type 2 diabetes mellitus	1.09e-05	6.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOA1—type 2 diabetes mellitus	1.09e-05	6.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT2—type 2 diabetes mellitus	1.08e-05	6.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTR—type 2 diabetes mellitus	1.08e-05	6.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.07e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.06e-05	6.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	1.06e-05	6.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	1.05e-05	6.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GCK—type 2 diabetes mellitus	1.05e-05	6.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IAPP—type 2 diabetes mellitus	1.04e-05	6.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.03e-05	6.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SERPINE1—type 2 diabetes mellitus	1.03e-05	6.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.03e-05	6.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.02e-05	6.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.01e-05	6.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.01e-05	6.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.97e-06	5.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—C3—type 2 diabetes mellitus	9.86e-06	5.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	9.85e-06	5.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3R1—type 2 diabetes mellitus	9.82e-06	5.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	9.59e-06	5.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARG—type 2 diabetes mellitus	9.56e-06	5.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—type 2 diabetes mellitus	9.5e-06	5.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.41e-06	5.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	9.4e-06	5.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	9.4e-06	5.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.38e-06	5.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—INS—type 2 diabetes mellitus	9.38e-06	5.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AGT—type 2 diabetes mellitus	9.37e-06	5.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—type 2 diabetes mellitus	9.33e-06	5.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.21e-06	5.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	9.2e-06	5.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOE—type 2 diabetes mellitus	9.18e-06	5.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LEP—type 2 diabetes mellitus	9.18e-06	5.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CYBA—type 2 diabetes mellitus	9.11e-06	5.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.08e-06	5.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	9.01e-06	5.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	9.01e-06	5.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—type 2 diabetes mellitus	8.99e-06	5.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—type 2 diabetes mellitus	8.98e-06	5.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	8.83e-06	5.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CALCA—type 2 diabetes mellitus	8.8e-06	5.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.78e-06	5.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	8.78e-06	5.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	8.78e-06	5.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	8.78e-06	5.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	8.73e-06	5.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.66e-06	5.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ALB—type 2 diabetes mellitus	8.6e-06	5.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	8.57e-06	5.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	8.5e-06	5.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	8.47e-06	5.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS1—type 2 diabetes mellitus	8.38e-06	5.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.32e-06	4.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—type 2 diabetes mellitus	8.29e-06	4.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	8.29e-06	4.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3R1—type 2 diabetes mellitus	8.23e-06	4.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.19e-06	4.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	8.15e-06	4.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.9e-06	4.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	7.87e-06	4.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	7.87e-06	4.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	7.87e-06	4.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—INS—type 2 diabetes mellitus	7.84e-06	4.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	7.73e-06	4.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.72e-06	4.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	7.66e-06	4.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.59e-06	4.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.58e-06	4.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.55e-06	4.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—type 2 diabetes mellitus	7.52e-06	4.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	7.5e-06	4.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SRC—type 2 diabetes mellitus	7.27e-06	4.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.21e-06	4.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.2e-06	4.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	7.12e-06	4.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.12e-06	4.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	7.09e-06	4.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—type 2 diabetes mellitus	6.95e-06	4.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.94e-06	4.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.88e-06	4.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	6.87e-06	4.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.83e-06	4.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	6.83e-06	4.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOB—type 2 diabetes mellitus	6.7e-06	4.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TGFB1—type 2 diabetes mellitus	6.5e-06	3.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RELA—type 2 diabetes mellitus	6.48e-06	3.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—LPL—type 2 diabetes mellitus	6.4e-06	3.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—type 2 diabetes mellitus	6.37e-06	3.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	6.26e-06	3.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	6e-06	3.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CCR5—type 2 diabetes mellitus	5.89e-06	3.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	5.88e-06	3.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.88e-06	3.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	5.86e-06	3.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.84e-06	3.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	5.78e-06	3.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	5.76e-06	3.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	5.61e-06	3.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.52e-06	3.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	5.49e-06	3.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IRS2—type 2 diabetes mellitus	5.48e-06	3.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.46e-06	3.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	5.46e-06	3.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—type 2 diabetes mellitus	5.46e-06	3.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CALM1—type 2 diabetes mellitus	5.38e-06	3.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOE—type 2 diabetes mellitus	5.36e-06	3.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	5.36e-06	3.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOA1—type 2 diabetes mellitus	5.3e-06	3.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	5.24e-06	3.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	5.23e-06	3.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	5.09e-06	3.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SRC—type 2 diabetes mellitus	5.09e-06	3.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.03e-06	3.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS2—type 2 diabetes mellitus	5e-06	2.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.96e-06	2.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—type 2 diabetes mellitus	4.89e-06	2.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	4.82e-06	2.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IRS1—type 2 diabetes mellitus	4.78e-06	2.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	4.73e-06	2.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	4.58e-06	2.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—INS—type 2 diabetes mellitus	4.58e-06	2.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.55e-06	2.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—type 2 diabetes mellitus	4.52e-06	2.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	4.51e-06	2.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	4.49e-06	2.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.46e-06	2.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	4.44e-06	2.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT2—type 2 diabetes mellitus	4.43e-06	2.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	4.21e-06	2.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.02e-06	2.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.02e-06	2.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	3.91e-06	2.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—INS—type 2 diabetes mellitus	3.84e-06	2.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—type 2 diabetes mellitus	3.78e-06	2.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	3.52e-06	2.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.43e-06	2.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-06	2.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-06	2.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.16e-06	1.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SRC—type 2 diabetes mellitus	2.97e-06	1.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	2.66e-06	1.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—type 2 diabetes mellitus	2.6e-06	1.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—type 2 diabetes mellitus	2e-06	1.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—type 2 diabetes mellitus	1.85e-06	1.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.55e-06	9.26e-06	CbGpPWpGaD
